New at CADTH — January 2022

News and Events

2022 Virtual Workshop Series
Registration is now open for the upcoming CADTH Workshop Series ―

• January 19 Rapid Reviews: From Decision Problem to Research and Decision-Making
• January 26 Conducting Economic Evaluations in Child Health
• February 2 Plain Language and Clearer Communication: Making Health Research Make Sense
• February 9 How to Use Statistical Methods and Person-Level Data in Economic Evaluations

CADTH Celebrated Digital Health Week
In celebration of Digital Health Week, CADTH shared some of the evidence we have delivered to inform decisions about digital health technologies in categories that span telemedicine, wearables, artificial intelligence, remote patient monitoring, and more.

2021 CADTH Symposium: On Demand Content
If you registered for the CADTH Symposium, don’t forget that you have access to all the content, on demand, for the next month.

New CADTH Review Aims to Help Health Systems Understand and Manage the Long-Term Impact of Post–COVID-19 Condition
In anticipation of the evolving needs of Canadian patients, policy-makers, and clinicians, CADTH is bringing stakeholders together and undertaking a range of work to inform practice and policy with evidence about how we identify, treat, and manage post–COVID-19 condition. Learn more about this upcoming work.

2021 CADTH Symposium Abstracts Published in the CADTH Canadian Journal of Health Technologies
The abstracts for the 2021 CADTH Symposium have been published in a special supplement to Volume 1, Number 12 of the CADTH Canadian Journal of Health Technologies. CADTH thanks all the authors, presenters, and participants who helped us build such a rich and diverse program for the 2021 CADTH Symposium.

CADTH Reimbursement Reviews

We recently issued the following Reimbursement Recommendations:

• chlormethine hydrochloride (Ledaga) for T-cell lymphoma
• zanubrutinib (Brukinsa) for Waldenström macroglobulinemia
• pembrolizumab (Keytruda) for esophageal carcinoma and gastroesophageal junction adenocarcinoma
• luspatercept (Reblozyl) for Myelodysplastic syndromes‒associated anemia

CADTH Horizon Scanning

We have published the following Horizon Scans:

• Self-Sampling Devices for HPV Testing ― Emerging Health Technologies
• An Overview of Emerging Point-of-Care Tests for Differentiating Bacterial and Viral Infections ― Emerging Health Technologies
• Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor ― Health Technology Update

CADTH Health Technology Reviews

We have published the following Health Technology Reviews:

• Cost-Effectiveness and Guidelines for Opioid Substitution Treatment ― Rapid Review
• Floatation Therapy for Mental Health Conditions ― Rapid Review
• Lung-RADS versus PanCan screening for patients at high risk of lung cancer ― Rapid Review
• Digital Pathology Using Primary Case Sign-Out ― Rapid Review
• Obstetrical Ultrasound During Pregnancy ― Rapid Review
• Contributing Factors to Acute Care Hospital Flow: International ideas ― Policy Insight
• International Plasma Collection Practices ― Environmental Scan

CADTH Reference Lists

We have published the following Reference Lists:

• Home-Based Withdrawal Management Services for Substance Use Disorder
• Compression Garments for People With Venous Leg Ulcers
• Anakinra Therapy for Inflammatory Response Syndromes

Other CADTH Tools

• Hospital News Article: Long COVID and what it means for a struggling health care system
• Biologics in Plaque Psoriasis: A Summary
• Considerations for the Implementation of Remote Monitoring Programs in Canada

TELL US WHAT YOU THINK

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.